Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

TIOBE Index for December 2025: Top 10 Most Popular Programming Languages Your email has been sent December’s TIOBE Index lands with a quieter top tier but a livelier shuffle just beneath it. The main ...

The NBA Cup is still pretty new, and basketball fans want to know why they should care. The league took a page out of the European soccer playbook when it implemented the in-season tournament to try ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

DROVE EMOTIONALLY CHARGED ARGUMENTS TO GET PEOPLE TO VOTE AGAINST THEIR IN SANTA CRUZ COUNTY TWO COMPETEING AFFORABLE HOUSING MEASURES WERE ON BOTH MEASURE B AND C ARE TAX INITIATIVES AIMING TO FUND ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Forbes contributors publish independent expert analyses and insights. Amir is Founder of AI unicorn Avathon & Boeing/SC JV, SkyGrid. Recently, a friend asked me a question that's been floating around ...

MOUNT PLEASANT, S.C. (WCBD) – WCBD News 2 has launched a Connected TV streaming app, WCBD+, offering live news, weather, and original programming – without a paid subscription. For more than 70 years, ...